FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

350071005: Product containing dinoprostone in vaginal dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2009. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3709621014 Dinoprostone-containing product in vaginal dose form en Synonym Active Entire term case insensitive SNOMED CT core module
3709622019 Product containing dinoprostone in vaginal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

9 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing dinoprostone in vaginal dose form (medicinal product form) Is a Product containing dinoprostone true Inferred relationship Existential restriction modifier
Product containing dinoprostone in vaginal dose form (medicinal product form) Has active ingredient Prostaglandin PGE>2< false Inferred relationship Existential restriction modifier
Product containing dinoprostone in vaginal dose form (medicinal product form) Has active ingredient Prostaglandin E>1< false Inferred relationship Existential restriction modifier
Product containing dinoprostone in vaginal dose form (medicinal product form) Has active ingredient Dinoprostone true Inferred relationship Existential restriction modifier 1
Product containing dinoprostone in vaginal dose form (medicinal product form) Has active ingredient Posterior pituitary hormone false Inferred relationship Existential restriction modifier
Product containing dinoprostone in vaginal dose form (medicinal product form) Has active ingredient Alprostadil false Inferred relationship Existential restriction modifier
Product containing dinoprostone in vaginal dose form (medicinal product form) Is a Product manufactured as vaginal dose form true Inferred relationship Existential restriction modifier
Product containing dinoprostone in vaginal dose form (medicinal product form) Has manufactured dose form Vaginal dose form true Inferred relationship Existential restriction modifier
Product containing dinoprostone in vaginal dose form (medicinal product form) Plays role Oxytocic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dinoprostone 10mg suppository Is a False Product containing dinoprostone in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel Is a False Product containing dinoprostone in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel Is a False Product containing dinoprostone in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Is a False Product containing dinoprostone in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing only dinoprostone in vaginal dose form (medicinal product form) Is a True Product containing dinoprostone in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Dinoprostone 500micrograms/2.5mL cervical gel Is a False Product containing dinoprostone in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start